Yaoxing Huang Selected Research

Carcinogenesis

12/2021

Long intergenic non-protein coding RNA 960 regulates cancer cell viability, migration and invasion through modulating miR-146a-5p/interleukin 1 receptor associated kinase 1 axis in pancreatic ductal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yaoxing Huang Research Topics

Disease

15	COVID-19 02/2022 - 01/2020
11	Infections 01/2022 - 09/2011
3	Human Influenza (Influenza) 12/2017 - 03/2011
3	Acquired Immunodeficiency Syndrome (AIDS) 04/2015 - 04/2008
2	Neoplasms (Cancer) 04/2022 - 12/2021
2	Severe Acute Respiratory Syndrome 04/2021 - 01/2020
2	Vaccinia 01/2010 - 04/2008
1	Breakthrough Infections 01/2022
1	Adenocarcinoma 12/2021
1	Carcinogenesis 12/2021
1	Communicable Diseases (Infectious Diseases) 12/2020
1	HIV Infections (HIV Infection) 08/2014
1	Diarrhea 06/2013
1	HIV Seropositivity 01/2010
1	Melanoma (Melanoma, Malignant) 02/2008

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 02/2022 - 04/2008
6	Monoclonal AntibodiesIBA 01/2021 - 08/2014
4	Pharmaceutical PreparationsIBA 01/2022 - 04/2015
3	RNA (Ribonucleic Acid)IBA 11/2021 - 11/2020
3	Broadly Neutralizing AntibodiesIBA 03/2021 - 08/2014
3	ChemokinesIBA 01/2021 - 01/2020
3	AntibodiesIBA 12/2020 - 01/2010
2	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2020
2	Neutralizing AntibodiesIBA 12/2021 - 04/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2022
1	COVID-19 VaccinesIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Biological ProductsIBA 12/2021
1	Interleukin-1 Receptor-Associated KinasesIBA 12/2021
1	Long Noncoding RNAIBA 12/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2021
1	xanthohumolIBA 11/2021
1	Hypoxia-Inducible Factor 1IBA 11/2021
1	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 11/2021
1	ND-646IBA 11/2021
1	GW 6471IBA 11/2021
1	Riluzole FDA LinkGeneric 05/2021
1	Imatinib Mesylate (Gleevec)FDA Link 05/2021
1	Dopamine (Intropin)FDA LinkGeneric 05/2021
1	Formaldehyde (Formol)FDA Link 05/2021
1	Metformin (Glucophage)FDA LinkGeneric 05/2021
1	ParaffinIBA 05/2021
1	Neuroprotective AgentsIBA 05/2021
1	SARS-CoV-2 spike proteinIBA 03/2021
1	Ferritins (Ferritin)IBA 03/2021
1	NanovaccinesIBA 03/2021
1	Single-Domain AntibodiesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	CytokinesIBA 05/2020
1	InterferonsIBA 05/2020
1	7- iodo- 8- hydroxy- 3- methyl- 1- (4- azidophenyl)- 2,3,4,5- tetrahydro- 1H- 3- benzazepineIBA 06/2016
1	Indicators and Reagents (Reagents)IBA 04/2015
1	aluminum sulfate (alum)IBA 06/2013
1	AntigensIBA 12/2011
1	Immunoglobulin G (IgG)IBA 12/2011
1	Anti-Infective Agents (Microbicides)IBA 09/2011
1	SugarsIBA 03/2011
1	Hemagglutinins (Hemagglutinin)IBA 03/2011
1	DNA VaccinesIBA 03/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2008

Therapy/Procedure

4	Therapeutics 01/2022 - 04/2015
1	Transplantation 05/2021
1	Immunotherapy 01/2021